Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Cerilliant
Federal Trade Commission
Cantor Fitzgerald
McKesson
Harvard Business School
Fish and Richardson
Cipla

Generated: May 22, 2018

DrugPatentWatch Database Preview

ZELAPAR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Zelapar patents expire, and when can generic versions of Zelapar launch?

Zelapar is a drug marketed by Valeant Pharm Intl and is included in one NDA.

The generic ingredient in ZELAPAR is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.
Drug patent expirations by year for ZELAPAR
Synonyms for ZELAPAR
(-)-(N)-Methyl-N-((1R)-1-methyl-2-phenylethyl)prop-2-yn-1-amine
(-)-Deprenil
(-)-deprenyl
(-)-selegiline
(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine
(r)-(-)-deprenyl
(R)-(-)-N-Methyl-N-(1-phenyl-2-propyl)-2-propinylamin
(r)-(-)-n,2-dimethyl-n-2-propynylphenethylamine
(R)-(-)-N,alpha-Dimethyl-N-2-propinylphenethylamine
(R)-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine
(r)-selegiline
14611-51-9
14611-52-0 (hydrochloride)
2079-54-1 (deprenyl.hydrochloride)
2K1V7GP655
AC1L1BTZ
AC1Q2860
AJ-74093
AK312654
AKOS000281115
Anipryl
API0009080
Apo-Selegiline
BDBM15579
Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)-
Benzeneethanamine, N,alpha-methyl-N-2-propynyl-, (alphaR)-
BPBio1_000687
BRD-K86434416-001-02-7
BRD-K86434416-003-03-1
BSPBio_000623
BSPBio_001589
C07245
Carbex
CHEBI:9086
CHEMBL972
D03731
D0S2UG
D0VC5L
DB01037
DTXSID6023575
Eldepryl
Emsam
Emsam (TN)
FT-0688371
Gen-Selegiline
GTPL6639
HMS1791P11
HMS1989P11
HMS2089D09
HMS3402P11
Jumex
L-Deprenalin
L-Deprenyl
l-E 250
LS-30156
methyl(1-phenylpropan-2-yl)(prop-2-yn-1-yl)amine
methyl[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-ylamine
MEZLKOACVSPNER-GFCCVEGCSA-N
N-methyl-N-[(1R)-1-methyl-2-phenylethyl]prop-2-yn-1-amine
N-methyl-N-[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-amine
NCGC00024994-01
NCGC00024994-02
NCGC00024994-03
NCGC00024994-04
Novo-Selegiline
Nu-Selegiline
Otrasel
Prestwick0_000552
Prestwick1_000552
Prestwick2_000552
Prestwick3_000552
R(-)-Selegiline solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
SCHEMBL22232
Sd Deprenyl
Selegeline Hcl
Selegene
Selegilina
Selegilina [INN-Spanish]
selegiline
Selegiline (transdermal, Parkinson's/depression)
Selegiline (USAN/INN)
Selegiline [INN:BAN]
Selegiline Hcl
Selegiline Transdermal System (STS) patch
Selegiline, (R)-Isomer
Selegilinum
Selegilinum [INN-Latin]
selegina
Selegyline
selgene
SPBio_002544
STK640578
UNII-2K1V7GP655
UNII-DPF682Q08V component MEZLKOACVSPNER-GFCCVEGCSA-N
US8633208, Deprenyl
Yumex
ZINC19632633
Zunrisa/Rezonic

US Patents and Regulatory Information for ZELAPAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for ZELAPAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl ZELAPAR selegiline hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 021479-001 Jun 14, 2006 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Baxter
Healthtrust
Mallinckrodt
Cipla
Merck
Chubb
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.